ProSciento’s Study Design and Protocol Development team is a recognized leader in developing protocols for first-in-human metabolic clinical trials. ProSciento is asked to contribute scientifically to nearly all study protocols and often provides full protocol development for its clients’ clinical drug and device programs, which includes later stage trials.
ProSciento’s team of highly experienced clinical development experts have longstanding expertise in developing protocols for metabolic programs, have in-depth knowledge of primary and secondary endpoints, and, most importantly, help clients steer clear of common challenges, such as unnecessarily complex study protocols, which can slow the development process and drive up costs.
